Literature DB >> 25138665

An in vitro model of innate lymphoid cell function and differentiation.

D S J Allan1, C L Kirkham1, O A Aguilar1, L C Qu1, P Chen1, J H Fine1, P Serra1, G Awong1, J L Gommerman2, J C Zúñiga-Pflücker1, J R Carlyle1.   

Abstract

Innate lymphoid cells (ILC) are RAG-independent lymphocytes with important roles in innate immunity, and include group-1 (natural killer (NK) cell, ILC1), group-2 (ILC2), and group-3 (lymphoid tissue inducer (LTi), NCR(+) ILC3) subsets. Group-3 ILC express Rorγt, produce interleukin (IL)-22, and are critically important in the normal function of mucosal tissues. Here, we describe a novel model cell line for the study of ILC function and differentiation. The parental MNK cell line, derived from NKR-P1B(+) fetal thymocytes, shows a capacity to differentiate in γc cytokines. One IL-7-responsive subline, designated MNK-3, expresses Rorγt and produces high levels of IL-22 in response to IL-23 and IL-1β stimulation. MNK-3 cells display surface markers and transcript expression characteristic of group-3 ILC, including IL-7Rα (CD127), c-kit (CD117), CCR6, Thy1 (CD90), RANK, RANKL, and lymphotoxin (LTα1β2). Using an in vitro assay of LTi cell activity, MNK-3 cells induce ICAM-1 and VCAM-1 expression on stromal cells in a manner dependent upon LTα1β2 expression. A second IL-2-responsive subline, MNK-1, expresses several NK cell receptors, perforin and granzymes, and shows some cytotoxic activity. Thus, MNK-1 cells serve as a model of ILC1/NK development and differentiation, whereas MNK-3 cells provide an attractive in vitro system to study the function of ILC3/LTi cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25138665     DOI: 10.1038/mi.2014.71

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  57 in total

1.  Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function.

Authors:  J R Carlyle; A Martin; A Mehra; L Attisano; F W Tsui; J C Zúñiga-Pflücker
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

Review 2.  Innate lymphoid cells: emerging insights in development, lineage relationships, and function.

Authors:  Hergen Spits; Tom Cupedo
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

Review 3.  Developmental programming of natural killer and innate lymphoid cells.

Authors:  Christian A J Vosshenrich; James P Di Santo
Journal:  Curr Opin Immunol       Date:  2013-03-13       Impact factor: 7.486

4.  Nonredundant function of soluble LTα3 produced by innate lymphoid cells in intestinal homeostasis.

Authors:  Andrey A Kruglov; Sergei I Grivennikov; Dmitry V Kuprash; Caroline Winsauer; Sandra Prepens; Gitta Maria Seleznik; Gerard Eberl; Dan R Littman; Mathias Heikenwalder; Alexei V Tumanov; Sergei A Nedospasov
Journal:  Science       Date:  2013-12-06       Impact factor: 47.728

5.  The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells.

Authors:  Ju Qiu; Jennifer J Heller; Xiaohuan Guo; Zong-ming E Chen; Kamonwan Fish; Yang-Xin Fu; Liang Zhou
Journal:  Immunity       Date:  2011-12-15       Impact factor: 31.745

6.  Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.

Authors:  Anja Fuchs; William Vermi; Jacob S Lee; Silvia Lonardi; Susan Gilfillan; Rodney D Newberry; Marina Cella; Marco Colonna
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

7.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

8.  Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis.

Authors:  Arthur Mortha; Aleksey Chudnovskiy; Daigo Hashimoto; Milena Bogunovic; Sean P Spencer; Yasmine Belkaid; Miriam Merad
Journal:  Science       Date:  2014-03-13       Impact factor: 47.728

9.  A committed precursor to innate lymphoid cells.

Authors:  Michael G Constantinides; Benjamin D McDonald; Philip A Verhoef; Albert Bendelac
Journal:  Nature       Date:  2014-02-09       Impact factor: 49.962

10.  RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla.

Authors:  Simona W Rossi; Mi-Yeon Kim; Andreas Leibbrandt; Sonia M Parnell; William E Jenkinson; Stephanie H Glanville; Fiona M McConnell; Hamish S Scott; Josef M Penninger; Eric J Jenkinson; Peter J L Lane; Graham Anderson
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

View more
  26 in total

1.  Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection.

Authors:  Panagiota Mamareli; Friederike Kruse; Chia-Wen Lu; Melanie Guderian; Stefan Floess; Katharina Rox; David S J Allan; James R Carlyle; Mark Brönstrup; Rolf Müller; Luciana Berod; Tim Sparwasser; Matthias Lochner
Journal:  Mucosal Immunol       Date:  2020-04-30       Impact factor: 7.313

2.  Multiple Levels of Control Determine How E4bp4/Nfil3 Regulates NK Cell Development.

Authors:  Tomasz Kostrzewski; Aaron J Borg; Yiran Meng; Iva Filipovic; Victoria Male; Andreas Wack; Peter A DiMaggio; Hugh J M Brady
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

Review 3.  Leaving no one behind: tracing every human thymocyte by single-cell RNA-sequencing.

Authors:  Yujun Deng; Hong Chen; Yang Zeng; Keyue Wang; Huiyuan Zhang; Hongbo Hu
Journal:  Semin Immunopathol       Date:  2021-01-15       Impact factor: 9.623

4.  ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients.

Authors:  Ahmet Eken; Murat Cansever; Fatma Zehra Okus; Serife Erdem; Ercan Nain; Zehra Busra Azizoglu; Yesim Haliloglu; Musa Karakukcu; Alper Ozcan; Omer Devecioglu; Guzide Aksu; Zeynep Arikan Ayyildiz; Erdem Topal; Elif Karakoc Aydiner; Ayca Kiykim; Ayse Metin; Funda Cipe; Aysenur Kaya; Hasibe Artac; Ismail Reisli; Sukru N Guner; Vedat Uygun; Gulsun Karasu; Hamiyet Dönmez Altuntas; Halit Canatan; Mohamed Oukka; Ahmet Ozen; Talal A Chatila; Sevgi Keles; Safa Baris; Ekrem Unal; Turkan Patiroglu
Journal:  Allergy       Date:  2019-10-31       Impact factor: 13.146

5.  NKR-P1B expression in gut-associated innate lymphoid cells is required for the control of gastrointestinal tract infections.

Authors:  Elias Abou-Samra; Zachary Hickey; Oscar A Aguilar; Michal Scur; Ahmad Bakur Mahmoud; Sergey Pyatibrat; Megan M Tu; Jeffrey Francispillai; Arthur Mortha; James R Carlyle; Mir Munir A Rahim; Andrew P Makrigiannis
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

6.  The orphan nuclear receptor ROR alpha and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn's disease.

Authors:  Bernard C Lo; Matthew J Gold; Michael R Hughes; Frann Antignano; Yanet Valdez; Colby Zaph; Kenneth W Harder; Kelly M McNagny
Journal:  Sci Immunol       Date:  2016-09-02

Review 7.  Emerging roles for antigen presentation in establishing host-microbiome symbiosis.

Authors:  Nicholas J Bessman; Gregory F Sonnenberg
Journal:  Immunol Rev       Date:  2016-07       Impact factor: 12.988

8.  Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.

Authors:  Marina Cella; Ramya Gamini; Cristiane Sécca; Patrick L Collins; Shanrong Zhao; Vincent Peng; Michelle L Robinette; Jorge Schettini; Konstantin Zaitsev; William Gordon; Jennifer K Bando; Kentaro Yomogida; Victor Cortez; Catrina Fronick; Robert Fulton; Lih-Ling Lin; Susan Gilfillan; Richard A Flavell; Liang Shan; Maxim N Artyomov; Michael Bowman; Eugene M Oltz; Scott A Jelinsky; Marco Colonna
Journal:  Nat Immunol       Date:  2019-06-17       Impact factor: 25.606

9.  Glucocorticoids Inhibit Group 3 Innate Lymphocyte IL-22 Production.

Authors:  Sudarshan Seshadri; Rosemary L Pope; Lauren A Zenewicz
Journal:  J Immunol       Date:  2018-07-06       Impact factor: 5.422

10.  Hypoxia enhances ILC3 responses through HIF-1α-dependent mechanism.

Authors:  J L Fachi; L P Pral; J A C Dos Santos; A C Codo; S de Oliveira; J S Felipe; F F F Zambom; N O S Câmara; P M M M Vieira; M Colonna; M A R Vinolo
Journal:  Mucosal Immunol       Date:  2021-01-14       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.